Business Context and Reporting Period
Company: Supernus Pharmaceuticals, Inc. (SUPN)
Filing Type: Form 8-K (Current Report)
Date of Report: April 23, 2025
Subject: Announcement of the timing for the release of First Quarter 2025 financial results.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely as a notification of the upcoming earnings release date.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing announces the schedule for the upcoming Q1 2025 results rather than reporting historical data.
Guidance, Outlook, and Management Commentary
- Earnings Release Date: The Company expects to report Q1 2025 results after market close on Tuesday, May 6, 2025.
- Conference Call: A conference call and webcast are scheduled for Tuesday, May 6, 2025, at 4:30 p.m. E.T.
- Reference: A press release detailing the announcement is included as Exhibit 99.1.
Investor Verification Checklist
- Verify the actual Q1 2025 financial results when released on May 6, 2025.
- Review the press release (Exhibit 99.1) for any additional context not included in the 8-K summary.
- Confirm participation in the conference call on May 6, 2025, at 4:30 p.m. E.T. for management commentary.